| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2002 | EP1228210A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 08/07/2002 | EP1228208A2 36p6d5: secreted tumor antigen |
| 08/07/2002 | EP1228202A2 Antisense compositions and cancer-treatment methods |
| 08/07/2002 | EP1228201A1 High order nucleic acid based structures |
| 08/07/2002 | EP1228125A2 Process for making aqueous coated beadlets |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228087A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228084A1 Production of polymorphic forms i and ii of finasteride by complexation with group i or ii metal salts |
| 08/07/2002 | EP1228083A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/07/2002 | EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 08/07/2002 | EP1228079A1 Novel fucosylated oligosaccharides and process for their preparation |
| 08/07/2002 | EP1228077A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 08/07/2002 | EP1228075A1 Silicon compounds derived from ascorbic acid |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds |
| 08/07/2002 | EP1228068A1 Polymorphic form of a tachykinin receptor antagonist |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228066A2 Sulfonamide derivatives |
| 08/07/2002 | EP1228065A1 (indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| 08/07/2002 | EP1228064A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228058A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 08/07/2002 | EP1228056A2 Method for the preparation of citalopram |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 08/07/2002 | EP1228052A1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 08/07/2002 | EP1228051A1 Semicarbazone derivatives and their use as thrombopoietin mimetics |
| 08/07/2002 | EP1228049A1 Antifungal sordaricin derivatives |
| 08/07/2002 | EP1228048A1 Sordaricin derivatives having antifungal activity |
| 08/07/2002 | EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228045A2 Heterocyclic cytotoxic agents |
| 08/07/2002 | EP1228044A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 08/07/2002 | EP1228043A1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228041A2 Indole derivatives and their use as 5ht2a ligands |
| 08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1228032A1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 08/07/2002 | EP1228031A2 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye |
| 08/07/2002 | EP1228030A2 Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
| 08/07/2002 | EP1228029A1 Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 08/07/2002 | EP1228028A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/07/2002 | EP1228027A2 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use |
| 08/07/2002 | EP1228026A2 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1227859A2 Neurophilin ligands for treating ocular conditions |
| 08/07/2002 | EP1227846A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 08/07/2002 | EP1227844A2 Compositions for treating atheroma and neoplastic tissue |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227834A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 08/07/2002 | EP1227831A2 Interferon gamma for the treatment of asthma |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | EP1227821A1 Therapeutic compositions and methods of use thereof |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227819A1 INHIBITING FtsZ PROTEIN (DE)POLYMERISATION |
| 08/07/2002 | EP1227818A2 Abc1 modulation for the modulation of cholesterol transport |
| 08/07/2002 | EP1227817A1 Ciclesonide-containing aqueous pharmaceutical composition |
| 08/07/2002 | EP1227816A1 Cholesterol lowering and blood lipids lowering composition |
| 08/07/2002 | EP1227815A1 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same |
| 08/07/2002 | EP1227814A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227812A2 Topical nasal treatment using desloratadine |
| 08/07/2002 | EP1227811A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |
| 08/07/2002 | EP1227810A1 Treating cancer by increasing intracellular malonyl coa levels |
| 08/07/2002 | EP1227809A2 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 08/07/2002 | EP1227807A2 Irrigation solution and method for inhibition of pain and inflammation |
| 08/07/2002 | EP1227806A1 Pharmaceutical formulation containing tolterodine and its use |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP1227804A2 Use of an aldosterone antagonist for treating restenosis |
| 08/07/2002 | EP1227803A2 Methods and compounds for inhibiting amyloid deposits |
| 08/07/2002 | EP1227800A1 Osmotic controlled release drug delivery device |
| 08/07/2002 | EP1227798A1 Controlled release hydrocodone formulations |
| 08/07/2002 | EP1227797A2 Solid dispersion pharmaceutical formulations |
| 08/07/2002 | EP1227795A2 Lipid complex of alkycyclines |
| 08/07/2002 | EP1227791A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 08/07/2002 | EP1227780A2 A stable aqueous dispersion of nutrients |
| 08/07/2002 | EP1227734A2 Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1227714A1 Method for producing metabolites from plants cultivated in soil-less medium |
| 08/07/2002 | EP1156789A4 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 08/07/2002 | EP1109527B1 Cosmetic composition |
| 08/07/2002 | EP1077981B1 Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same |
| 08/07/2002 | EP1077976B1 Water soluble azoles as broad-spectrum antifungals |
| 08/07/2002 | EP1069892B1 Therapeutic system which can be moisture-activated |
| 08/07/2002 | EP1058679A4 Synthesis of epothilones, intermediates thereto and analogues therof |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/07/2002 | EP1019016B1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 08/07/2002 | EP1016665B1 Process for the selective preparation of z-isomers of 3-(2-substituted vinyl)cephalosporins |